{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:37:17Z","timestamp":1780407437554,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2018T059"],"award-info":[{"award-number":["2018T059"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2020T058"],"award-info":[{"award-number":["2020T058"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["917.18.338"],"award-info":[{"award-number":["917.18.338"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.healun.2022.05.007","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T02:30:39Z","timestamp":1653013839000},"page":"1075-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-4139","authenticated-orcid":false,"given":"Azar","family":"Kianzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-5445","authenticated-orcid":false,"given":"Jessie","family":"van Wezenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas R.","family":"Celant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.T","family":"Oosterveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Vonk Noordegraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7528-8307","authenticated-orcid":false,"given":"Lilian J.","family":"Meijboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances S.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-0346","authenticated-orcid":false,"given":"Harm Jan","family":"Bogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-7865","authenticated-orcid":false,"given":"M. Louis","family":"Handoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.05.007_bib0001","first-page":"177","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"69","author":"Gali\u00e8","year":"2016","journal-title":"Revista espanola de cardiologia (English ed)"},{"key":"10.1016\/j.healun.2022.05.007_bib0002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2022.05.007_bib0003","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","article-title":"Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland","volume":"186","author":"Ling","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.05.007_bib0004","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","article-title":"Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry","volume":"168","author":"Hoeper","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.05.007_bib0005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.05.007_bib0006","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jacc.2016.05.047","article-title":"Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum","volume":"68","author":"Opitz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.05.007_bib0007","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.healun.2022.05.007_bib0008","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial","volume":"36","author":"Hoendermis","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.05.007_bib0009","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.05.007_bib0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/678512","article-title":"Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors","volume":"4","author":"Charalampopoulos","year":"2014","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2022.05.007_bib0011","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1183\/09031936.00184412","article-title":"Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","volume":"42","author":"Trip","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.05.007_bib0012","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, edvidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.05.007_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.120.050757","article-title":"Evaluation of 2 existing diagnostic scores for heart failure with preserved ejection fraction against a comprehensively phenotyped cohort","volume":"143","author":"Churchill","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.05.007_bib0014","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.05.007_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.healun.2012.09.022","article-title":"Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension","volume":"32","author":"Trip","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.05.007_bib0016","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1161\/01.CIR.0000147612.59751.4C","article-title":"Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism","volume":"110","author":"Schoepf","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.05.007_bib0017","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10554-015-0618-x","article-title":"Predicting pulmonary hypertension with standard computed tomography pulmonary angiography","volume":"31","author":"Spruijt","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.05.007_bib0018","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ijcard.2016.08.314","article-title":"CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension","volume":"223","author":"Huis In 't Veld","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.05.007_bib0019","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"Hoeper","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"6 suppl 2","key":"10.1016\/j.healun.2022.05.007_bib0020","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.2214\/AJR.04.1868","article-title":"Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity","volume":"186","author":"Natori","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.healun.2022.05.007_bib0021","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jcmg.2013.05.014","article-title":"LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF","volume":"6","author":"Crawley","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.healun.2022.05.007_bib0022","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijcard.2005.08.049","article-title":"Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial size","volume":"110","author":"Rossi","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.05.007_bib0023","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.05.007_bib0024","article-title":"COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension","author":"Hoeper","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.05.007_bib0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.10-0075","article-title":"The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries","volume":"139","author":"Frost","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.05.007_bib0026","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.healun.2019.09.010","article-title":"Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: results from the AMBITION trial","volume":"38","author":"McLaughlin","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.05.007_bib0027","article-title":"Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension","volume":"51","author":"Hjalmarsson","year":"2018","journal-title":"EurRespir J"},{"key":"10.1016\/j.healun.2022.05.007_bib0028","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.chest.2018.05.006","article-title":"Association between BMI and obesity with survival in pulmonary arterial hypertension","volume":"154","author":"Weatherald","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.05.007_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014195","article-title":"Obesity is associated with pulmonary hypertension and modifies outcomes","volume":"9","author":"Frank","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.05.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769874","article-title":"Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact","volume":"8","author":"Mercurio","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2022.05.007_bib0031","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cardfail.2019.07.547","article-title":"Hemodynamic effects of pulmonary arterial hypertension-specific therapy in patients with heart failure with preserved ejection fraction and with combined post- and precapillay pulmonary hypertension","volume":"26","author":"Huis In't Veld","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.05.007_bib0032","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCHEARTFAILURE.114.001192","article-title":"Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"7","author":"Mohammed","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.05.007_bib0033","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/eurheartj\/ehy809","article-title":"Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction","volume":"40","author":"Obokata","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.05.007_bib0034","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822019490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822019490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:14:11Z","timestamp":1762355651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822019490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1053249822019490"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.05.007","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}